Avoro Capital Advisors’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Avoro Capital Advisors’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,199,342	Closed	-$102M	–	49
2023 Q2	$102M	Sell	2,199,342 -1,750,658	-44%	-$60.5M	1.39%	17
2023 Q1	$113M	Buy	3,950,000 +1,424,445	+56%	+$42.2M	1.68%	17
2022 Q4	$78.8M	Buy	2,525,555 +1,450,555	+135%	+$47.3M	1.18%	18
2022 Q3	$21.8M	Hold	1,075,000	–	–	0.4%	30
2022 Q2	$16.7M	Hold	1,075,000	–	–	0.33%	31
2022 Q1	$20.6M	Buy	1,075,000 +512,500	+91%	+$9.15M	0.38%	33
2021 Q4	$14.2M	Sell	562,500 -237,500	-30%	-$6.96M	0.24%	35
2021 Q3	$26.2M	Buy	+800,000	New	+$27.2M	0.41%	34

Avoro Capital Advisors's DICE Position: Q3 2023 in Review

Avoro Capital Advisors sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 2,199,342 shares — an estimated $102M sold.

Avoro Capital Advisors first reported a position in DICE in Q3 2021 and held it in 8 quarters. The position peaked at $113M in Q1 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

Avoro Capital Advisors reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Avoro Capital Advisors sold 2,199,342 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $102M.
Avoro Capital Advisors first reported a position in DICE Therapeutics, Inc. Common Stock in Q3 2021 and held it in 8 quarters.
Avoro Capital Advisors's DICE Therapeutics, Inc. Common Stock position peaked at $113M in Q1 2023.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Avoro Capital Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.